Discrepancies in estradiol levels in a premenopausal woman receiving abemaciclib despite ovarian function suppression and bilateral salpingo-oophorectomy

Discrepancies in estradiol levels in a premenopausal woman receiving abemaciclib despite ovarian function suppression and bilateral salpingo-oophorectomy

Abemaciclib is approved for use in the adjuvant setting in combination with endocrine therapy for patients with high-risk, hormone receptor-positive, HER2-negative early-stage breast cancer based on the monarchE trial. Options for endocrine therapy for premenopausal women include an aromatase inhibi...

Full description

Bibliographic Details
Main Authors:	Alaina J. Kessler, Rima Patel, Emily Jane Gallagher, Theresa Shao, Julie Fasano
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Series:	Current Problems in Cancer: Case Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666621923000091

Similar Items

Risk-reducing salpingo-oophorectomy for hereditary ovarian cancer
by: FENG Zheng, WEN Hao
Published: (2022-11-01)

Bone density loss after risk reducing salpingo-oophorectomy
by: Andrews L, et al.
Published: (2012-04-01)

The uterine adenosarcoma with postoperative residual in a woman treated by total abdominal hysterectomy/bilateral salpingo‐oophorectomy: A case report and review of literature
by: Pedram Fadavi, et al.
Published: (2023-10-01)

Hormone Levels and Sexual Functioning After Risk-Reducing Salpingo-Oophorectomy
by: Nora Johansen, MD, et al.
Published: (2018-06-01)

21 Hormone replacement therapy utilization over time following risk-reducing salpingo-oophorectomy in premenopausal patients at high risk for ovarian cancer
by: Talayeh Ghezelayagh, et al.
Published: (2023-06-01)

Squamous cell carcinoma occurring in the pelvis after total hysterectomy and bilateral salpingo-oophorectomy for an ovarian mature teratoma with malignant transformation
by: Pu Chen, et al.
Published: (2012-09-01)

Impact of lower co-payments on risk-reducing salpingo-oophorectomy and BRCA testing in Japan
by: Katsuyuki Konnai, et al.
Published: (2023-02-01)

Risk-reducing salpingo-oophorectomy among Chinese women at increased risk of breast and ovarian cancer
by: Zheng Feng, et al.
Published: (2023-06-01)

Utility Scores for Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy: Mapping to EQ-5D
by: Samuel G. Oxley, et al.
Published: (2024-03-01)

Risk-Reducing Bilateral Salpingo-Oophorectomy for BRCA Mutation Carriers and Hormonal Replacement Therapy: If It Should Rain, Better a Drizzle than a Storm
by: Maria Luisa Gasparri, et al.
Published: (2019-07-01)

Impact of the coverage of risk-reducing salpingo-oophorectomy by the national insurance system for women with BRCA pathogenic variants in Japan
by: Hidetaka Nomura, et al.
Published: (2023-01-01)

<i>BRCA</i> Genetic Test and Risk-Reducing Salpingo-Oophorectomy for Hereditary Breast and Ovarian Cancer: State-of-the-Art
by: Masayuki Sekine, et al.
Published: (2021-05-01)

Risks of stroke and heart disease following hysterectomy and oophorectomy in Chinese premenopausal women
by: Poorthuis, M, et al.
Published: (2022)

Risk of Fracture After Bilateral Oophorectomy
by: Trine K Hueg, et al.
Published: (2023-07-01)

Long-Term Non-Cancer Risks in People with <i>BRCA</i> Mutations following Risk-Reducing Bilateral Salpingo-Oophorectomy and the Role of Hormone Replacement Therapy: A Review
by: Amanda S. Nitschke, et al.
Published: (2023-01-01)

Development of Peritoneal Carcinoma in women diagnosed with Serous Tubal Intraepithelial Carcinoma (STIC) following Risk-Reducing Salpingo-Oophorectomy (RRSO)
by: P. I. Stanciu, et al.
Published: (2019-05-01)

An explainable machine learning ensemble model to predict the risk of ovarian cancer in BRCA-mutated patients undergoing risk-reducing salpingo-oophorectomy
by: Maria Colomba Comes, et al.
Published: (2023-07-01)

Bilateral vulvar lipomas in a premenopausal woman: A case report
by: Ashley Thakur, et al.
Published: (2022-10-01)

Serum estradiol levels decrease after oophorectomy in transmasculine individuals on testosterone therapy
by: Sahil Kumar, et al.
Published: (2023-01-01)

The Psychosocial Impact of the Decision to Undergo Risk-Reducing Salpingo-Oophorectomy Surgery in <i>BRCA</i> Mutation Carriers and the Role of Physician-Patient Communication
by: Ana C. Alves-Nogueira, et al.
Published: (2023-02-01)

Prophylactic salpingo-oophorectomy & surgical menopause for inherited risks of cancer: the need to identify biomarkers to assess the theoretical risk of premature coronary artery disease
by: Zarah Batulan, et al.
Published: (2018-04-01)

Oophorectomy in Premenopausal Patients with Estrogen Receptor-Positive Breast Cancer: New Insights into Long-Term Effects
by: Fatima Khan, et al.
Published: (2023-02-01)

Risk-Reducing Salpingo-Oophorectomy (RRSO) Combined with Simultaneous Mastectomy in Women with BRCA 1–2 Mutation Carriers: The Surgical Technique, the Feasibility and Patients’ Satisfaction of Multiple Surgeries
by: Carlo Saccardi, et al.
Published: (2022-12-01)

Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in <i>BRCA</i> Carriers: A Systematic Review and Meta-Analysis
by: Faiza Gaba, et al.
Published: (2023-03-01)

Ovarian vein thrombosis after hysterectomy with bilateral salpingectomy: With versus without oophorectomy
by: Yoshifumi Takahashi, et al.
Published: (2023-07-01)

The Effect of Risk-Reducing Salpingo-Oophorectomy on Breast Cancer Incidence and Histopathological Features in Women with a <i>BRCA1</i> or <i>BRCA2</i> Germline Pathogenic Variant
by: Annechien Stuursma, et al.
Published: (2023-03-01)

Theory‐based behavior change intervention to increase uptake of risk‐reducing salpingo‐oophorectomy in women with a BRCA1 or BRCA2 pathogenic variant: The PREVENT randomized controlled trial
by: Kelly A. Metcalfe, et al.
Published: (2023-09-01)

A Case of Prepubertal Ovarian Tissue Cryopreservation in Metachronous Bilateral Mature Ovarian Teratoma Requiring Bilateral Oophorectomy
by: Tom Malik, et al.
Published: (2022-01-01)

17β-Estradiol protects female rats from bilateral oophorectomy-induced nonalcoholic fatty liver disease induced by improving linoleic acid metabolism alteration and gut microbiota disturbance
by: Ying Tian, et al.
Published: (2024-04-01)

Total laparoscopic hysterectomy and bilateral salpingo-oophrectomy for stage 1 endometrial carcinoma under regional anaesthesia
by: Abdalla Fayyad, et al.
Published: (2023-08-01)

A population-based cohort study on the risk of obstructive lung disease after bilateral oophorectomy
by: Trinh T. Nguyen, et al.
Published: (2022-11-01)

Endogenous estradiol contributes to vascular endothelial dysfunction in premenopausal women with type 1 diabetes
by: Abigayle B. Simon, et al.
Published: (2023-09-01)

Bilateral thecoma presenting as premenopausal hirsutism: Laproscopic removal
by: S Ramkumar, et al.
Published: (2013-01-01)

Prevalence and Outcomes of Unilateral Versus Bilateral Oophorectomy in Women With Ovarian Cancer: A Population-Based Study
by: Jiaqiang Xiong, et al.
Published: (2022-07-01)

Pure transitional cell carcinoma of the ovary presenting as bilateral complex cystic masses in a premenopausal woman – Case report and review of literature
by: Garima Yadav, et al.
Published: (2019-01-01)

Tuberculous Salpingitis - possible cause of salpingo-enteric fistula
by: Shayan Sirat Maheen Anwar, MBBS, FCPS, et al.
Published: (2023-02-01)

Opposite effects of estradiol and progesterone on woman's disgust processing
by: Mei Liu, et al.
Published: (2023-04-01)

Coitus induced vaginal evisceration in a premenopausal woman: a case report
by: Bagali Nasheen M, et al.
Published: (2011-04-01)

Oophorectomy with plastronotomy in a red-eared slider
by: Ezgi VATANSEVER, et al.
Published: (2018-04-01)

Efficiency and tolerability of abemaciclib in elderly patients
by: E. I. Kovalenko, et al.
Published: (2020-12-01)